Effectiveness of cardioneuroablation in different subtypes of vasovagal syncopeOA
Effectiveness of cardioneuroablation in different subtypes of vasovagal syncope
BACKGROUND Cardioneuroablation(CNA)has shown encouraging results in patients with vasovagal syncope(VVS).How-ever,data on different subtypes was scarce. METHODS This observational study retrospectively enrolled 141 patients[mean age:40±18 years,51 males(36.2%)]with the di-agnosis of VVS.The characteristics among different types of VVS and the outcomes after CNA were analyzed. RESULTS After a mean follow-up of 4.3±1.5 years,41 patients(29.1%)experienced syncope/pre-syncope events after CNA.Syn-cope/pre-syncope recurrence significantly differed in each subtype(P=0.04).The cardioinhibitory type of VVS had the lowest re-currence rate after the procedure(n=6,16.7%),followed by mixed(n=26,30.6%)and vasodepressive(n=9,45.0%).Additionally,a significant difference was observed in the analyses of the Kaplan-Meier survival curve(P=0.02).Syncope/pre-syncope burden was significantly reduced after CNA in the vasodepressive type(P<0.01).Vasodepressive types with recurrent syncope/pre-syncope after CNA have a lower baseline deceleration capacity(DC)level than those without(7.4±1.0 ms vs.9.0±1.6 ms,P=0.01).Patie-nts with DC<8.4 ms had an 8.1(HR=8.1,95%CI:2.2-30.0,P=0.02)times risk of syncope/pre-syncope recurrence after CNA com-pared to patients with DC ≥ 8.4 ms,and this association still existed after adjusting for age and sex(HR=8.1,95%CI:2.2-30.1,P=0.02). CONCLUSIONS Different subtypes exhibit different event-free rates.The vasodepressive type exhibited the lowest event-free rate,but those patients with DC ≥ 8.4 ms might benefit from CNA.
Bin TU;Zi-Hao LAI;Ai-Yue CHEN;Zhi-Yuan WENG;Si-Min CAI;Zhu-Xin ZHANG;Li-Kun ZHOU;Li-Hui ZHENG;Yan YAO
Arrhythmia Center,Fuwai Hospital,National Center for Cardiovascular Diseases,National Key Laboratory,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China||Cardiac Center,Beijing Chaoyang Ho-spital,Capital Medical University,Beijing,ChinaArrhythmia Center,Fuwai Hospital,National Center for Cardiovascular Diseases,National Key Laboratory,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaCardiovascular Department,The First Affiliated Hospital,Fujian Medical University,Fujian Institute of Hypertension,Fujian,ChinaDepartment of Cardiovascular,The Second Affili-ated Hospital of Zhejiang University School of Medicine,Zhejiang,China
《老年心脏病学杂志(英文版)》 2024 (006)
651-657 / 7
This study was supported by the CAMS Central Pub-lic Welfare Scientific Research Institute Basal Research Expenses(No.2021-XCGC09-1 & No.2022-I2M-C&T-B-045),the Beijing Municipal Science & Technology Com-mission(Z191100006619019),and the High-level Hospit-al Clinical Scientific Research Business Fees(No.2022-GSP-QZ-4).All authors had no conflicts of interest to dis-close.
评论